SCIASCIA THOMAS (Chief Medical Officer) sold 19.9% of their position (53.37K shares) of TREVI THERAPEUTICS, INC. on the open market
Open‑market sale worth $136.1K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/31/2024ACC: 0000950170-24-067305
Officer10% Owner· Chief Medical Officer
Since May 2019
-53.37K
Net shares
Net seller
$136.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
59.35K acquired · 112.72K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+59.35K
Price / share
$2.19
Trade value
$129.99K
% of position
28.5%
5/29/2024
208.45K→267.80K
Common Stock
Direct
Shares
−53.37K
Price / share
$2.55
Trade value
$136.11K
% of position
19.9%
5/29/2024
267.80K→214.43K
Total
Net shares
+5.99K
Net value
-$6.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/29/2024 | M · Option Exercise | +59.35K | $2.19 | $129.99K | 28.5% | 208.45K | 267.80K |
| Common Stock Direct | 5/29/2024 | S · Sale | −53.37K | $2.55 | $136.11K | 19.9% | 267.80K | 214.43K |
| Total | +5.99K | -$6.12K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
59.35K shares
Shares
−59.35K
Strike price
2.19
Held after
0.00
Exercisable
—
5/29/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock59.35K shares | 5/29/2024 | M · Option Exercise | −59.35K | 2.19 | — | 0.00 |